Trulieve Cannabis Corp (TCNNF)
11.31
-1.09
(-8.79%)
USD |
OTCM |
May 06, 16:01
Trulieve Cannabis Enterprise Value: 2.598B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.598B |
| May 02, 2024 | 2.571B |
| May 01, 2024 | 2.504B |
| April 30, 2024 | 2.967B |
| April 29, 2024 | 2.223B |
| April 26, 2024 | 2.255B |
| April 25, 2024 | 2.182B |
| April 24, 2024 | 2.299B |
| April 23, 2024 | 2.258B |
| April 22, 2024 | 2.250B |
| April 19, 2024 | 2.276B |
| April 18, 2024 | 2.403B |
| April 17, 2024 | 2.474B |
| April 16, 2024 | 2.269B |
| April 15, 2024 | 2.330B |
| April 12, 2024 | 2.376B |
| April 11, 2024 | 2.509B |
| April 10, 2024 | 2.530B |
| April 09, 2024 | 2.598B |
| April 08, 2024 | 2.559B |
| April 05, 2024 | 2.623B |
| April 04, 2024 | 2.427B |
| April 03, 2024 | 2.707B |
| April 02, 2024 | 2.585B |
| April 01, 2024 | 2.612B |
| Date | Value |
|---|---|
| March 28, 2024 | 2.585B |
| March 27, 2024 | 2.543B |
| March 26, 2024 | 2.420B |
| March 25, 2024 | 2.379B |
| March 22, 2024 | 2.483B |
| March 21, 2024 | 2.511B |
| March 20, 2024 | 2.346B |
| March 19, 2024 | 2.401B |
| March 18, 2024 | 2.492B |
| March 15, 2024 | 2.308B |
| March 14, 2024 | 2.094B |
| March 13, 2024 | 2.081B |
| March 12, 2024 | 1.989B |
| March 11, 2024 | 2.010B |
| March 08, 2024 | 2.138B |
| March 07, 2024 | 2.036B |
| March 06, 2024 | 2.055B |
| March 05, 2024 | 2.148B |
| March 04, 2024 | 2.170B |
| March 01, 2024 | 2.211B |
| February 29, 2024 | 2.079B |
| February 28, 2024 | 2.101B |
| February 27, 2024 | 2.092B |
| February 26, 2024 | 2.137B |
| February 23, 2024 | 2.207B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
589.17M
Minimum
Mar 18 2020
6.300B
Maximum
Mar 16 2021
2.427B
Average
2.096B
Median
Enterprise Value Benchmarks
| Flora Growth Corp | 15.64M |
| Tilray Brands Inc | 1.854B |
| Clever Leaves Holdings Inc | -2.630M |
| Arbutus Biopharma Corp | 362.27M |
| Chimerix Inc | -97.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.43M |
| Revenue (Quarterly) | 286.97M |
| Total Expenses (Quarterly) | 256.61M |
| EPS Diluted (Quarterly) | -0.18 |
| Gross Profit Margin (Quarterly) | 53.61% |
| Profit Margin (Quarterly) | -11.65% |
| Earnings Yield | -21.75% |
| Operating Earnings Yield | 4.21% |
| Normalized Earnings Yield | -9.249 |